TY - JOUR
T1 - Genomic reconstruction of the SARS-CoV-2 epidemic in England
AU - The Wellcome Sanger Institute COVID-19 Surveillance Team
AU - The COVID-19 Genomics UK (COG-UK) Consortium
AU - Vöhringer, Harald S.
AU - Sanderson, Theo
AU - Sinnott, Matthew
AU - De Maio, Nicola
AU - Nguyen, Thuy
AU - Goater, Richard
AU - Schwach, Frank
AU - Harrison, Ian
AU - Hellewell, Joel
AU - Ariani, Cristina V.
AU - Gonçalves, Sonia
AU - Jackson, David K.
AU - Johnston, Ian
AU - Jung, Alexander W.
AU - Saint, Callum
AU - Sillitoe, John
AU - Suciu, Maria
AU - Goldman, Nick
AU - Panovska-Griffiths, Jasmina
AU - Abnizova, Irina
AU - Aigrain, Louise
AU - Alderton, Alex
AU - Ali, Mozam
AU - Allen, Laura
AU - Amato, Roberto
AU - Anderson, Ralph
AU - Ariani, Cristina
AU - Austin-Guest, Siobhan
AU - Bala, Sendu
AU - Barrett, Jeffrey
AU - Bassett, Andrew
AU - Battleday, Kristina
AU - Beal, James
AU - Beale, Mathew
AU - Beaver, Charlotte
AU - Bellany, Sam
AU - Bellerby, Tristram
AU - Bellis, Katie
AU - Berger, Duncan
AU - Berriman, Matt
AU - Betteridge, Emma
AU - Bevan, Paul
AU - Binley, Simon
AU - Bishop, Jason
AU - Blackburn, Kirsty
AU - Bonfield, James
AU - Boughton, Nick
AU - Bowker, Sam
AU - Brendler-Spaeth, Timothy
AU - Gutierrez, Bernardo
N1 - Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12/16
Y1 - 2021/12/16
N2 - The evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus leads to new variants that warrant timely epidemiological characterization. Here we use the dense genomic surveillance data generated by the COVID-19 Genomics UK Consortium to reconstruct the dynamics of 71 different lineages in each of 315 English local authorities between September 2020 and June 2021. This analysis reveals a series of subepidemics that peaked in early autumn 2020, followed by a jump in transmissibility of the B.1.1.7/Alpha lineage. The Alpha variant grew when other lineages declined during the second national lockdown and regionally tiered restrictions between November and December 2020. A third more stringent national lockdown suppressed the Alpha variant and eliminated nearly all other lineages in early 2021. Yet a series of variants (most of which contained the spike E484K mutation) defied these trends and persisted at moderately increasing proportions. However, by accounting for sustained introductions, we found that the transmissibility of these variants is unlikely to have exceeded the transmissibility of the Alpha variant. Finally, B.1.617.2/Delta was repeatedly introduced in England and grew rapidly in early summer 2021, constituting approximately 98% of sampled SARS-CoV-2 genomes on 26 June 2021.
AB - The evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus leads to new variants that warrant timely epidemiological characterization. Here we use the dense genomic surveillance data generated by the COVID-19 Genomics UK Consortium to reconstruct the dynamics of 71 different lineages in each of 315 English local authorities between September 2020 and June 2021. This analysis reveals a series of subepidemics that peaked in early autumn 2020, followed by a jump in transmissibility of the B.1.1.7/Alpha lineage. The Alpha variant grew when other lineages declined during the second national lockdown and regionally tiered restrictions between November and December 2020. A third more stringent national lockdown suppressed the Alpha variant and eliminated nearly all other lineages in early 2021. Yet a series of variants (most of which contained the spike E484K mutation) defied these trends and persisted at moderately increasing proportions. However, by accounting for sustained introductions, we found that the transmissibility of these variants is unlikely to have exceeded the transmissibility of the Alpha variant. Finally, B.1.617.2/Delta was repeatedly introduced in England and grew rapidly in early summer 2021, constituting approximately 98% of sampled SARS-CoV-2 genomes on 26 June 2021.
UR - http://www.scopus.com/inward/record.url?scp=85117501846&partnerID=8YFLogxK
U2 - 10.1038/s41586-021-04069-y
DO - 10.1038/s41586-021-04069-y
M3 - Artículo
C2 - 34649268
AN - SCOPUS:85117501846
SN - 0028-0836
VL - 600
SP - 506
EP - 511
JO - Nature
JF - Nature
IS - 7889
ER -